Hysteroscopy pp 181-191 | Cite as

Hysteroscopy and Retained Products of Conception

  • Luis Alonso Pacheco
  • Laura Nieto Pascual
  • Beatriz Garcia Mourin
  • Miguel Rodrigo Olmedo
Chapter

Abstract

The existence of intrauterine residual trophoblastic tissue can be observed after an abortion, miscarriage, or parturition. The classical clinical presentation of retained products of conception (RPOC) is abnormal uterine bleeding after a term of pregnancy. The amounts of this bleeding may be slight or profuse. The diagnosis is based on a previous history of pregnancy, clinical symptoms, and diagnostic tools such as ultrasound and hysteroscopy. Various options have been proposed for the treatment of retained products of conception including expectant management, medical and surgical treatment. The use of hysteroscopy in patients with RPOC helps to establish an accurate and reliable diagnosis and allows for the selective resection of the residual tissue under direct visualization.

Keywords

Retained products of conception Placenta polyp Hysteroscopy Surgery Vaginal bleeding Pregnancy complications Doppler ultrasound 

References

  1. 1.
    Hakim-Elahi E, Tovell H, Burnhill M. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76(1):129–35.PubMedGoogle Scholar
  2. 2.
    Kahn JG, Becker BJ, MacIsaa L, Amory JK, Neuhaus J, Olkin I, et al. The efficacy of medical abortion: a meta-analysis. Contraception. 2000;61(1):29–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Ikhena DE, Bortoletto P, Lawson AK, Confino R, Marsh EE, Milad MP, et al. Reproductive outcomes after hysteroscopic resection of retained products of conception. J Minim Invasive Gynecol. 2016;23(7):1070–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Baba T, Endo T, Ikeda K, Shimizu A, Morishita M, Kuno Y, et al. Assisted reproductive technique increases the risk of placental polyp. Gynecol Endocrinol. 2013;29(6):611–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Baer BF. Placental polypus which simulated malignant disease of the uterus. Philadelphia Med Times. 1884;15:175.Google Scholar
  6. 6.
    Tchabo JG. Use of contact hysteroscopy in evaluating postpartum bleeding and incomplete abortion. J Reprod Med. 1984;29(10):749–51.PubMedGoogle Scholar
  7. 7.
    Goldenberg M, Schiff E, Achiron R, Lipitz S, Mashiach S. Managing residual trophoblastic tissue. Hysteroscopy for directing curettage. J Reprod Med. 1997;42(1):26–8.PubMedGoogle Scholar
  8. 8.
    Swan RW, Woodruff JD. Retained products of conception. Histologic viability of placental polyps. Obstet Gynecol. 1969;34(4):506–14.PubMedGoogle Scholar
  9. 9.
    Ranney B. Relative atony of myometrium underlying the placental site secondary to high cornual implantation; a major cause of retained placentas. Am J Obstet Gynecol. 1956;71(5):1049–61.CrossRefPubMedGoogle Scholar
  10. 10.
    van den Bosch T, Daemen A, Van Schoubroeck D, Pochet N, De Moor B, Timmerman D. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med. 2008;27(3):357–61.CrossRefPubMedGoogle Scholar
  11. 11.
    Faivre E, Deffieux X, Mrazguia C, Gervaise A, Chauveaud-Lambling A, Frydman R, et al. Hysteroscopic management of residual trophoblastic tissue and reproductive outcome: a pilot study. J Minim Invasive Gynecol. 2009;16(4):487–90.CrossRefPubMedGoogle Scholar
  12. 12.
    Dyer I, Bradburn DM. An inquiry into the etiology of placental polyps. Am J Obstet Gynecol. 1971;09:858–67.CrossRefGoogle Scholar
  13. 13.
    Hatada Y. An unexpected case of placental polyp with villi devoid of cytotrophoblastic cells. J Obstet Gynaecol. 2004;24(2):193–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Lawrence WD, Qureshi F, Bonakdar MI. “Placental polyp”: light microscopic and immunohistochemical observations. Hum Pathol. 1988;19(12):1467–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Durfee SM, Frates MC, Luong A, Benson CB. The sonographic and color Doppler features of retained products of conception. J Ultrasound Med. 2005;24(9):1181–6. quiz 1188–9CrossRefPubMedGoogle Scholar
  16. 16.
    Mulic-Lutvica A, Bekuretsion M, Bakos O, Axelsson O. Ultrasonic evaluation of the uterus and uterine cavity after normal, vaginal delivery. Ultrasound Obstet Gynecol. 2001;18(5):491–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Bar-Hava I, Ashkenazi S, Orvieto R, et al. Spectrum of normal intrauterine cavity sonographic findings after first-trimester abortion. J Ultrasound Med. 2001;20:1277.CrossRefPubMedGoogle Scholar
  18. 18.
    Ustunyurt E, Kaymak O, Iskender C, Ustunyurt OB, Celik C, Danisman N. Role of transvaginal sonography in the diagnosis of retained products of conception. Arch Gynecol Obstet. 2008;277(2):151–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Kamaya A, Petrovitch I, Chen B, Frederick CE, Jeffrey RB. Retained products of conception: spectrum of color Doppler findings. J Ultrasound Med. 2009;28(8):1031–41.CrossRefPubMedGoogle Scholar
  20. 20.
    Noonan JB, Coakley FV, Qayyum A, Yeh BM, Wu L, Chen LM. MR imaging of retained products of conception. AJR Am J Roentgenol. 2003;181(2):435–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Shanthi V, Rao NM, Lava nya G, Krishna BA, Mohan KV. Placental polyp – a rare case report. Turk Patoloji Derg. 2015;31(1):77–9.PubMedGoogle Scholar
  22. 22.
    Timmerman D, Wauters J, Van Calenbergh S, et al. Color Doppler imaging is a valuable tool for the diagnosis and management of uterine vascular malformations. Ultrasound Obstet Gynecol. 2003;21(6):570–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Kelly SM, Belli AM, Campbell S. Arteriovenous malformation of the uterus associated with secondary postpartum hemorrhage. Ultrasound Obstet Gynecol. 2003;21(6):602–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Kim SJ. Placental site trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):969–84.CrossRefPubMedGoogle Scholar
  25. 25.
    Jauniaux E. Ultrasound diagnosis and follow-up of gestational trophoblastic disease. Ultrasound Obstet Gynecol. 1998;11(5):367–77.CrossRefPubMedGoogle Scholar
  26. 26.
    Tuncalp O, Gulmezoglu AM, Souza JP. Surgical procedures for evacuating incomplete miscarriage. Cochrane Database Syst Rev. 2010;(9):CD001993.Google Scholar
  27. 27.
    Forna F, Gulmezoglu AM. Surgical procedures to evacuate incomplete abortion. Cochrane Database Syst Rev 2001;(1):CD001993.Google Scholar
  28. 28.
    Hassan R, Bhal K, Joseph B. The need for repeat evacuation of retained products of conception: how common is it? J Obstet Gynaecol. 2013;33(1):75–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Cohen SB, Kalter-Ferber A, Weisz BS, Zalel Y, Seidman DS, Mashiach S, et al. Hysteroscopy may be the method of choice for management of residual trophoblastic tissue. J Am Assoc Gynecol Laparosc. 2001;8(2):199–202.CrossRefPubMedGoogle Scholar
  30. 30.
    Romer T. Post-abortion-hysteroscopy—a method for early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol. 1994;57(3):171–3.CrossRefPubMedGoogle Scholar
  31. 31.
    Westendorp IC, Ankum WM, Mol BW, Vonk J. Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod. 1998;13(12):3347–50.CrossRefPubMedGoogle Scholar
  32. 32.
    Amarin ZO, Badria LF. A survey of uterine perforation following dilatation and curettage or evacuation of retained products of conception. Arch Gynecol Obstet. 2005;271(3):203–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Wijesinghe PS, Padumadasa GS, Palihawadana TS, Marleen FS. A trial of expectant management in incomplete miscarriage. Ceylon Med J. 2011;56(1):10–3.CrossRefPubMedGoogle Scholar
  34. 34.
    Hiraki K, Khan KN, Kitajima M, Fujishita A, Masuzaki H. Uterine preservation surgery for placental polyp. J Obstet Gynaecol Res. 2014;40(1):89–95.CrossRefPubMedGoogle Scholar
  35. 35.
    Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynaecol Obstet. 2007;99(Suppl 2):S186–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Graziosi GC, Mol BW, Reuwer PJ, Drogtrop A, Bruinse HW. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Hum Reprod. 2004;19(8):1894–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Goldfarb HA. D&C results improved by hysteroscopy. N J Med. 1989;86(4):277–9.PubMedGoogle Scholar
  38. 38.
    Ben-Ami I, Ofir T, Melcer Y, Smorgick N, Schneider D, Pansky M, et al. Infertility following retained products of conception: is it the surgical procedure or the presence of trophoblastic tissue? Eur J Obstet Gynecol Reprod Biol. 2014;182:132–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Takeda A, Koyama K, Imoto S, Mori M, Sakai K, Nakamura H. Computed tomographic angiography in diagnosis and management of placental polyp with neovascularization. Arch Gynecol Obstet. 2010;281(5):823–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Rein DT, Schmidt T, Hess AP, Volkmer A, Schondorf T, Breidenbach M. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011;18(6):774–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Luis Alonso Pacheco
    • 1
  • Laura Nieto Pascual
    • 2
  • Beatriz Garcia Mourin
    • 3
  • Miguel Rodrigo Olmedo
    • 4
  1. 1.Unidad Endoscopia Centro Gutenberg 1Unidad de Reproducción Asistida de QuirónsaludMálagaSpain
  2. 2.Hospital Universitario Reina Sofía 3CórdobaSpain
  3. 3.Unidad Endoscopia Clínica Victoria 4MálagaSpain
  4. 4.Unidad Endoscopia Centro Gutenberg 1MálagaSpain

Personalised recommendations